Testing a sleep medicine for epilepsy-related insomnia
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have epilepsy that causes seizures during sleep (sleep-related focal epilepsy).
- You are using birth control (if you could become pregnant) to prevent pregnancy during the study.
- You have not changed your seizure medication in the past month and will not change it during the study.
- You do not have serious liver, lung, or breathing problems.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have narcolepsy, a history of sleepwalking, or severe mental health conditions like depression or suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sleep medication called lemborexant to see if it helps people who work rotating shifts sleep better and feel less sleepy during their shifts.
This trial tests if lemborexant, a sleep medication, can help prevent confusion (delirium) after open-heart surgery. If you are having heart surgery through a chest incision, you may be able to join.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.
This trial tests whether a medication called Lemborexant can improve sleep problems and movement symptoms in people with Parkinson's disease. If you have trouble sleeping due to insomnia and have had Parkinson's for at least 2 years, this study may help.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.